Hyperprolactinemia and galactorrhea: Spontaneous versus iatrogenic hypothyroidism
Author
dc.contributor.author
Serrano Contreras, Patricio
Author
dc.contributor.author
Generini, Gladys
Author
dc.contributor.author
Michelsen, Harold
Author
dc.contributor.author
Pumarino, Hugo
Author
dc.contributor.author
Campino, Carmen
Admission date
dc.date.accessioned
2019-01-29T14:20:30Z
Available date
dc.date.available
2019-01-29T14:20:30Z
Publication date
dc.date.issued
1981
Cita de ítem
dc.identifier.citation
Journal of Clinical Endocrinology and Metabolism, Volumen 53, Issue 5, 2018, Pages 1036-1039
Identifier
dc.identifier.issn
19457197
Identifier
dc.identifier.issn
0021972X
Identifier
dc.identifier.other
10.1210/jcem-53-5-1036
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/160421
Abstract
dc.description.abstract
Although hyperprolactinemia and galactorrhea occur in primary hypothyroidism, factors influencing their presence are not well established. To further define these factors, the duration of illness and serum levels of PRL and TSH were investigated in a group of 50 patients with spontaneous (27 females and 7 males) and iatrogenic (16 females) primary hypothyroidism. To test the hypothesis of reduced hypothalamic dopamine content in overt long-standing primary hypothyroidism, the percent increase in serum PRL after the administration of metoclopramide, a dopamine blocker (2.5 mg, iv bolus), was studied in 13 women with spontaneous primary hypothyroidism and compared with that in 10 euthyroid women. While 88.2% of the patients with spontaneous primary hypothyroidism were hyperprolactinemic, only 31% of those with iatrogenic disease had elevated PRL levels. Women with spontaneous primary hypothyroidism had a longer duration of illness (72 ± 12 vs. 6.7 ± 1.8 months; P < 0.001) and higher seru